Inventiva (IVA) Current Deferred Revenue (2018 - 2025)
Inventiva (IVA) recorded quarterly Current Deferred Revenue of $1.2 million in Q2 2025, up 36584.79% quarter-over-quarter from $3230.7 in Q2 2024, and up 36584.79% on a YoY basis from N/an in Q2 2024.
Inventiva (IVA) Current Deferred Revenue (2018 - 2025) Analysis & Trends
Inventiva's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $1.2 million for Q2 2025.
- In Q2 2025, Current Deferred Revenue rose 36584.79% year-over-year to $1.2 million; the TTM figure through Jun 2025 stood at $1.2 million (up 36584.79% YoY), while the FY2023 annual figure was $6455.6, up 5.46% from the prior year.
- Current Deferred Revenue was $1.2 million for Q2 2025 at Inventiva, up from $3230.7 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q2 2025 to a low of $3230.7 in Q2 2024.
- Historically, Current Deferred Revenue has averaged $360419.8 across 4 years, with a median of $6494.6 in 2023.
- The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue tumbled 99.32% in 2023, then soared 36584.79% in 2025.
- A 4-year view of Current Deferred Revenue shows it stood at $6121.5 in 2022, then grew by 5.46% to $6455.6 in 2023, then tumbled by 49.96% to $3230.7 in 2024, then jumped by 36584.79% to $1.2 million in 2025.
- The last three Current Deferred Revenue figures came in at $1.2 million (Q2 2025), $3230.7 (Q2 2024), and $6455.6 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.19 Mn |
| Jun 30, 2024 | 3,230.66 |
| Dec 31, 2023 | 6,455.64 |
| Jun 30, 2023 | 6,533.55 |
| Dec 31, 2022 | 6,121.48 |
| Jun 30, 2022 | 955,015.74 |
| Dec 31, 2018 | 625,485.24 |